AstraZeneca Secures Injunction Blocking Pharmacor's Generic Diabetes Drug Launch in Australia
Mar 10, 2026
AstraZeneca won a Federal Court injunction blocking Pharmacor from selling generic dapagliflozin products in Australia until a full patent trial. The patent expires October 22, 2027.